Many US Food and Drug Administration user fees for drugs and biosimilars increased for fiscal year 2023, with a few notable exceptions.
US FDA's FY 2023 User Fees Finally Revealed
Several fees for prescription drug, generic drug, and biosimilar applications are set to increase, although some also will drop.
